0001801885-21-000002.txt : 20210806 0001801885-21-000002.hdr.sgml : 20210806 20210806172920 ACCESSION NUMBER: 0001801885-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 EFFECTIVENESS DATE: 20210806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oisin Biotechnologies, Inc. CENTRAL INDEX KEY: 0001801885 IRS NUMBER: 465167496 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-409178 FILM NUMBER: 211153966 BUSINESS ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-880-1166 MAIL ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001801885 Oisin Biotechnologies, Inc. 701 5TH AVENUE, SUITE 4200 SEATTLE WA WASHINGTON 98104 206-880-1166 DELAWARE None None Corporation true Matthew Scholz 701 5th Avenue, Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Director Gary Hudson 701 Fifth Avenue, Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Director David Gobel 701 Fifth Avenue, Suite 4200 Seattle WA WASHINGTON 98104 Director Eric Garcia 701 Fifth Avenue, Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Stephen Hilbert 701 Fifth Avenue, Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Other Decline to Disclose 06b false 2021-07-24 false true true true true SAFEs false 0 5000000 475000 4525000 false 8 0 0 0 false Oisin Biotechnologies, Inc. /s/ Matthew Scholz Matthew Scholz President & CEO 2021-08-05